-
Study aim
-
Comparison of bolus injection and continuous epidural infusion of lidocaine 1% on pain, normal delivery and motor function in patients with epidural analgesia
-
Design
-
50 patients are entered into a randomized, single-blind, phase 2-3 clinical trial and randomly assigned into 4 blocks and entered into one of the two groups of continuous and bolus epidural analgesia.
-
Settings and conduct
-
After placing catheter in epidural space, eligible patients in the Fatemieh Hospital of Hamedan received 10 ml of lidocaine 1% in epidural space and randomly placed in one of two groups of bolus or continuous and two types of analgesia is given . However, evaluator and patient do not know how to drug inject.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria : Patients aged 16 to 45; First pregnancy; Failure to receive previous analgesic; Vertex presentation; ASA class 1 and 2
Exclusion criteria: Epidural anesthetic contraindications (coagulation problems, hypovolemia, local infection, high ICP and anemia); ASA class 3 and 4; Poor collaboration in epidural analgesia; Failure to cooperate in answering questionnaire questions
-
Intervention groups
-
After placing catheter in epidural space, in both groups, 10 ml lidocaine 1% plus 1 ml of sufentanil is injected through the catheter into epidural space by anesthetist. Then, in bolus group, every 1 hour, 10 ml lidocaine 1% is injected regularly and in continuous group, lidocaine 1% is infused through a continuous infusion pump at a rate of 10 ml / h in epidural space until delivery.
-
Main outcome variables
-
Both groups are evaluated for VAS of pain and vital signs every 10 minutes. Also, total dose of lidocaine; nausea and vomiting; delivery progress; level of sensory and motor block and patient's satisfaction with analgesia during delivery is examined by anesthetic nurse and is recorded in questionnaire.